Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study

Anna Mazzeo, Antonio Toscano, Maria L. Stromillo, Marco Battaglini, Corrado Messina, Antonio Federico, Giuseppe Vita, Nicola De Stefano

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: To assess brain metabolic abnormalities in patients with familial amyloid polyneuropathy (FAP) due to the transthyretin (TTR) gene mutations. Background: The TTR-FAP has variable phenotypic expression, which includes abnormalities of the central nervous system (CNS). Several conventional MRI studies have shown brain abnormalities, probably secondary to amyloid accumulation in leptomeningeal and subarachnoid vessels. However, TTR-related amyloid deposits do not seem to significantly affect the brain parenchyma and a prominent CNS impairment is considered to be rare in TTR amyloidosis. Methods: We performed proton MR spectroscopic imaging (1H-MRSI) in the central brain of four unrelated TTR-FAP patients with either minimal or no signs of neurological involvement and eight age- and sex-matched normal controls (NC). Metabolic changes were assessed in the entire volume of interest (VOI) and in the frontal, periventricular and posterior white matter (WM). Results: Conventional MRI was normal in 2 patients and showed minimal WM lesions in the remaining 2 patients. 1H-MRSI showed N-acetylaspartate to creatine ratio (NAA/Cr) decreases in the central brain VOI in all TTR-FAP patients (p <0.005). These NAA/Cr decreases were homogeneous in all WM regions (p <0.05 for all). Conclusions: 1H-MRSI findings suggest that diffuse metabolic changes, probably related to axonal damage, are present in brains of TTR-FAP patients even when they have no or minimal clinical and MRI signs of CNS involvement. The mechanism leading to sub-clinical metabolic brain changes needs to be identified.

Original languageEnglish
Pages (from-to)31-35
Number of pages5
JournalJournal of the Neurological Sciences
Volume246
Issue number1-2
DOIs
Publication statusPublished - Jul 15 2006

Fingerprint

Familial Amyloid Neuropathies
Prealbumin
Protons
Brain
Central Nervous System
Creatine
Amyloid Plaques
Amyloid
Mutation

Keywords

  • Axonal damage
  • Brain
  • Familial amyloid polyneuropathy
  • Magnetic resonance spectroscopy

ASJC Scopus subject areas

  • Ageing
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Mazzeo, A., Toscano, A., Stromillo, M. L., Battaglini, M., Messina, C., Federico, A., ... De Stefano, N. (2006). Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study. Journal of the Neurological Sciences, 246(1-2), 31-35. https://doi.org/10.1016/j.jns.2006.01.017

Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study. / Mazzeo, Anna; Toscano, Antonio; Stromillo, Maria L.; Battaglini, Marco; Messina, Corrado; Federico, Antonio; Vita, Giuseppe; De Stefano, Nicola.

In: Journal of the Neurological Sciences, Vol. 246, No. 1-2, 15.07.2006, p. 31-35.

Research output: Contribution to journalArticle

Mazzeo, A, Toscano, A, Stromillo, ML, Battaglini, M, Messina, C, Federico, A, Vita, G & De Stefano, N 2006, 'Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study', Journal of the Neurological Sciences, vol. 246, no. 1-2, pp. 31-35. https://doi.org/10.1016/j.jns.2006.01.017
Mazzeo, Anna ; Toscano, Antonio ; Stromillo, Maria L. ; Battaglini, Marco ; Messina, Corrado ; Federico, Antonio ; Vita, Giuseppe ; De Stefano, Nicola. / Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study. In: Journal of the Neurological Sciences. 2006 ; Vol. 246, No. 1-2. pp. 31-35.
@article{c20245acb5424e2c8ab3bcd1e81b8002,
title = "Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study",
abstract = "Objectives: To assess brain metabolic abnormalities in patients with familial amyloid polyneuropathy (FAP) due to the transthyretin (TTR) gene mutations. Background: The TTR-FAP has variable phenotypic expression, which includes abnormalities of the central nervous system (CNS). Several conventional MRI studies have shown brain abnormalities, probably secondary to amyloid accumulation in leptomeningeal and subarachnoid vessels. However, TTR-related amyloid deposits do not seem to significantly affect the brain parenchyma and a prominent CNS impairment is considered to be rare in TTR amyloidosis. Methods: We performed proton MR spectroscopic imaging (1H-MRSI) in the central brain of four unrelated TTR-FAP patients with either minimal or no signs of neurological involvement and eight age- and sex-matched normal controls (NC). Metabolic changes were assessed in the entire volume of interest (VOI) and in the frontal, periventricular and posterior white matter (WM). Results: Conventional MRI was normal in 2 patients and showed minimal WM lesions in the remaining 2 patients. 1H-MRSI showed N-acetylaspartate to creatine ratio (NAA/Cr) decreases in the central brain VOI in all TTR-FAP patients (p <0.005). These NAA/Cr decreases were homogeneous in all WM regions (p <0.05 for all). Conclusions: 1H-MRSI findings suggest that diffuse metabolic changes, probably related to axonal damage, are present in brains of TTR-FAP patients even when they have no or minimal clinical and MRI signs of CNS involvement. The mechanism leading to sub-clinical metabolic brain changes needs to be identified.",
keywords = "Axonal damage, Brain, Familial amyloid polyneuropathy, Magnetic resonance spectroscopy",
author = "Anna Mazzeo and Antonio Toscano and Stromillo, {Maria L.} and Marco Battaglini and Corrado Messina and Antonio Federico and Giuseppe Vita and {De Stefano}, Nicola",
year = "2006",
month = "7",
day = "15",
doi = "10.1016/j.jns.2006.01.017",
language = "English",
volume = "246",
pages = "31--35",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study

AU - Mazzeo, Anna

AU - Toscano, Antonio

AU - Stromillo, Maria L.

AU - Battaglini, Marco

AU - Messina, Corrado

AU - Federico, Antonio

AU - Vita, Giuseppe

AU - De Stefano, Nicola

PY - 2006/7/15

Y1 - 2006/7/15

N2 - Objectives: To assess brain metabolic abnormalities in patients with familial amyloid polyneuropathy (FAP) due to the transthyretin (TTR) gene mutations. Background: The TTR-FAP has variable phenotypic expression, which includes abnormalities of the central nervous system (CNS). Several conventional MRI studies have shown brain abnormalities, probably secondary to amyloid accumulation in leptomeningeal and subarachnoid vessels. However, TTR-related amyloid deposits do not seem to significantly affect the brain parenchyma and a prominent CNS impairment is considered to be rare in TTR amyloidosis. Methods: We performed proton MR spectroscopic imaging (1H-MRSI) in the central brain of four unrelated TTR-FAP patients with either minimal or no signs of neurological involvement and eight age- and sex-matched normal controls (NC). Metabolic changes were assessed in the entire volume of interest (VOI) and in the frontal, periventricular and posterior white matter (WM). Results: Conventional MRI was normal in 2 patients and showed minimal WM lesions in the remaining 2 patients. 1H-MRSI showed N-acetylaspartate to creatine ratio (NAA/Cr) decreases in the central brain VOI in all TTR-FAP patients (p <0.005). These NAA/Cr decreases were homogeneous in all WM regions (p <0.05 for all). Conclusions: 1H-MRSI findings suggest that diffuse metabolic changes, probably related to axonal damage, are present in brains of TTR-FAP patients even when they have no or minimal clinical and MRI signs of CNS involvement. The mechanism leading to sub-clinical metabolic brain changes needs to be identified.

AB - Objectives: To assess brain metabolic abnormalities in patients with familial amyloid polyneuropathy (FAP) due to the transthyretin (TTR) gene mutations. Background: The TTR-FAP has variable phenotypic expression, which includes abnormalities of the central nervous system (CNS). Several conventional MRI studies have shown brain abnormalities, probably secondary to amyloid accumulation in leptomeningeal and subarachnoid vessels. However, TTR-related amyloid deposits do not seem to significantly affect the brain parenchyma and a prominent CNS impairment is considered to be rare in TTR amyloidosis. Methods: We performed proton MR spectroscopic imaging (1H-MRSI) in the central brain of four unrelated TTR-FAP patients with either minimal or no signs of neurological involvement and eight age- and sex-matched normal controls (NC). Metabolic changes were assessed in the entire volume of interest (VOI) and in the frontal, periventricular and posterior white matter (WM). Results: Conventional MRI was normal in 2 patients and showed minimal WM lesions in the remaining 2 patients. 1H-MRSI showed N-acetylaspartate to creatine ratio (NAA/Cr) decreases in the central brain VOI in all TTR-FAP patients (p <0.005). These NAA/Cr decreases were homogeneous in all WM regions (p <0.05 for all). Conclusions: 1H-MRSI findings suggest that diffuse metabolic changes, probably related to axonal damage, are present in brains of TTR-FAP patients even when they have no or minimal clinical and MRI signs of CNS involvement. The mechanism leading to sub-clinical metabolic brain changes needs to be identified.

KW - Axonal damage

KW - Brain

KW - Familial amyloid polyneuropathy

KW - Magnetic resonance spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=33744505181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744505181&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2006.01.017

DO - 10.1016/j.jns.2006.01.017

M3 - Article

VL - 246

SP - 31

EP - 35

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -